Keyphrases
Older Patients
100%
Comorbidity
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Busulfan
100%
Myeloablative
100%
Comorbidity Index
100%
Non-relapse Mortality
80%
Index Score
40%
Mortality Rate
20%
Hematological Malignancies
20%
Overall Survival
20%
Chronic Myeloid Leukemia
20%
Transplantation
20%
Phase II Trial
20%
Antileukemic Activity
20%
Acute Leukemia
20%
Am(III)
20%
Relapse Rate
20%
Myelodysplastic Syndrome
20%
Conditioning Regimen
20%
Fludarabine
20%
Myeloproliferative Neoplasms
20%
Area under the Curve
20%
Relapse Incidence
20%
Matched Related
20%
Matched Unrelated
20%
Extended Period
20%
Whole Course
20%
Suboptimal Outcome
20%
Medicine and Dentistry
Comorbidity
100%
Busulfan
100%
Stem Cell Transplant
100%
Hematopoietic Cell
25%
Cell Transplantation
25%
Mortality Rate
12%
Overall Survival
12%
Outpatient
12%
Acute Leukemia
12%
Recurrence Risk
12%
Chronic Myelogenous Leukemia
12%
Transplantation
12%
Hematologic Malignancy
12%
Myelodysplastic Syndrome
12%
Fludarabine
12%
Conditioning
12%
Myeloproliferative Disorder
12%
Pharmacology, Toxicology and Pharmaceutical Science
Comorbidity
100%
Busulfan
100%
Mortality Rate
12%
Hematologic Malignancy
12%
Overall Survival
12%
Chronic Myeloid Leukemia
12%
Acute Leukemia
12%
Myelodysplastic Syndrome
12%
Recurrence Risk
12%
Fludarabine
12%
Myeloproliferative Disorder
12%
Immunology and Microbiology
Comorbidity
100%
Stem Cell Transplant
100%
Hematopoietic Cell
25%
Cell Transplantation
25%
Myeloid
12%
Overall Survival
12%
Conditioning
12%
Mortality Rate
12%